Andrew P. Ohl

Learn More
  • DMUND J. L EWIS, AWRENCE G. H UNSICKER, +4 authors I Ohde
  • 2001
A BSTRACT Background It is unknown whether either the angiotensin-II–receptor blocker irbesartan or the calcium-channel blocker amlodipine slows the progression of nephropathy in patients with type 2(More)
  • 1